APA Zitierstil

Rapoport, M. J., Sharabi, A., Aharoni, D., Bloch, O., Zinger, H., Dayan, M., & Mozes, E. (2005). Amelioration of SLE-like manifestations in (NZBxNZW)F1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK kinase. Clinical immunology (Orlando, Fla.), 117(3), 262.

Chicago Zitierstil

Rapoport, Micha J., Amir Sharabi, Dorit Aharoni, Olga Bloch, Heidy Zinger, Molly Dayan, und Edna Mozes. "Amelioration of SLE-like Manifestations in (NZBxNZW)F1 Mice Following Treatment with a Peptide Based on the Complementarity Determining Region 1 of an Autoantibody Is Associated with a Down-regulation of Apoptosis and of the Pro-apoptotic Factor JNK Kinase." Clinical Immunology (Orlando, Fla.) 117, no. 3 (2005): 262.

MLA Zitierstil

Rapoport, Micha J., et al. "Amelioration of SLE-like Manifestations in (NZBxNZW)F1 Mice Following Treatment with a Peptide Based on the Complementarity Determining Region 1 of an Autoantibody Is Associated with a Down-regulation of Apoptosis and of the Pro-apoptotic Factor JNK Kinase." Clinical Immunology (Orlando, Fla.), vol. 117, no. 3, 2005, p. 262.